Search Results
Mar 02, 2026, 08:30 ET Canyon Partners Announces $400 Million of Commitments for Fourth CLO Equity Fund
consistently access the market."Temporary market dislocations provide our team with more opportunities to apply our active approach and trading DNA to seek to enhance performance through tactical issuer and sector adjustments," said Martin Downen, Partner and Co-Head of Canyon's CLO business. "Our
More news about: Canyon Partners LLC
Mar 02, 2026, 08:30 ET Xtalks Announces its Life Science Webinar Calendar for March 2026
ScoringMar 31 - Drug Development Insights: What New Industry Data Reveals for 2026LABORATORY TECHNOLOGYMar 17 - Optimizing DNA Yield in Self-Collected Samples Through Advanced MaterialsMar 24 - Evaluating the Impact of Cell Culture Supplements on CHO Clonal Outgrowth
More news about: Xtalks
Mar 02, 2026, 08:02 ET Checkers & Rally's Unveils New Flatbread Sandwich Combos Starting at Just $5
This offer is also available for a limited time at participating locations nationwide."Bold, innovative flavor and unbeatable value are in our DNA," said Scott Johnson, Chief Marketing Officer of Checkers Drive-In Restaurants, Inc. "With these Flatbread sandwiches, we've taken two guest favorites
More news about: Checkers Drive-In Restaurants, Inc.
Mar 02, 2026, 08:00 ET Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure
BOSTON, March 2, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced the official launch of Ginkgo Cloud Lab. This new interface allows researchers to transition their benchwork to Ginkgo's autonomous lab infrastructure
More news about: Ginkgo Bioworks
Mar 02, 2026, 04:00 ET TECNO Expands AI Ecosystem at MWC 2026, Forging the "Connection of Intelligence"
fully integrated gaming and entertainment suite, including POVA Metal, a game controller and an earphone, all infused with the distinct POVA design DNA. These forward-looking explorations underscore TECNO's commitment to continuous R&D and its ambition to shape the next of intelligent devices. Edge-Side
More news about: TECNO MOBILE LTD
Mar 01, 2026, 19:35 ET SK Telecom CEO Unveils 'AI Native' Strategy at MWC26, Driving Korea's Leap in AI Innovation
infrastructure and large-scale investment plans.This strategy reflects SKT's ambition to redesign its telecommunications leadership DNA into an AI-driven DNA, building on its core strengths, and to lead Korea's leap toward becoming one of the world's top three AI leaders through bold challenges
More news about: SK Telecom
Feb 27, 2026, 09:15 ET Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida
IlluminaIllumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in
More news about: Illumina, Inc.
Feb 27, 2026, 07:00 ET Matricelf Ltd. (TASE: MTLF) Appoints Ron Mayron as Chairman of the Board
multiple public and private life sciences companies, including SimpliVity, InnoCan Pharma, IceCure Medical, BioLight, G Medical, Kadimastem, Entera Bio, DNA Biomedical Solutions, and Earmada . His broad board level experience spans biotechnology, medical devices, pharmaceuticals, and advanced therapeutic
More news about: Matricelf Ltd.
Feb 26, 2026, 19:24 ET Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics
SAN DIEGO, Feb. 27, 2026 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a suite of powerful advancements that will significantly accelerate the next era of genomic
More news about: Illumina
Feb 26, 2026, 16:26 ET Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business
resultsBOSTON, Feb. 26, 2026 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced its results for the fourth quarter and full year ended December 31, 2025. The update, including a webcast slide presentation
More news about: Ginkgo Bioworks
Feb 26, 2026, 14:59 ET Março Lilás: Casos de câncer de colo do útero devem crescer 14% no Brasil(1, 2)
pública6.A recomendação da OMS inclui a vacinação contra o HPV, a realização de exames de rotina (Papanicolau e o teste de DNA-HPV7) e o tratamento adequado de lesões pré-cancerígenas6.Diante desse cenário de saúde pública, a MSD Brasil, em parceria
More news about: MSD Brasil
Feb 26, 2026, 14:50 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO
development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papilloma virus ("HPV"). The Company's DNA medicines are comprised of two components: (i) DNA plasmids, which are small circular DNA molecules that purportedly work like
More news about: Pomerantz LLP
Feb 26, 2026, 12:08 ET Dr. Adrienne O'Connell Introduces SKINformed: A Medical-Grade Skincare Line Rooted in Science, Integrity, and Results
trust. Her concierge approach to aesthetics emphasizes individualized care, education, and natural-looking results. These values are woven into the DNA of SKINformed.Founded in 2025, SKINformed reflects Dr. O'Connell's belief that powerful skincare should feel both intelligent and indulgent; where
More news about: SKINformed Skincare
Feb 26, 2026, 11:16 ET Volta Labs beflügelt die AGBT 2026 mit bedeutenden Produkteinführungen und branchenprägenden Partnerschaften
versuchen, den AXELIOS 1 SBX-D-Vorbereitungs-Workflow in die Callisto-Plattform zu integrieren. Callisto verfügt bereits über integrierte DNA-Extraktions-Workflows, die eine optimierte End-to-End-Lösung ermöglichen.Unser Ziel ist es, sicherzustellen, dass Kunden, die Sequenzierer der nächsten Generation
More news about: Volta Labs Inc.
Feb 26, 2026, 10:52 ET Advanced Materials for Vaginal Self-Collection Enabling High-Quality DNA Isolation, Upcoming Webinar Hosted by Xtalks
Discover how material innovation can improve DNA recovery from human samples and support the development of reliable non-invasive sampling devices. In this free webinar, attendees will learn how collection materials influence sample quality, transport stability, and biomolecule
More news about: Xtalks
Feb 26, 2026, 10:30 ET Inovio Pharmaceuticals, Inc. Stock Alert: INO Stockholders Who Lost Money in the Company Should Contact Robbins LLP for Information on How to Recover Their Losses
securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus ("HPV").
More news about: Robbins LLP
Feb 26, 2026, 09:15 ET Havas Health and BrightInsight Forge Exclusive Alliance to Tackle Pharma's $500B+ Patient Problem
platform with Havas' deep strategic influence and global reach, we can ensure that digital health solutions are successfully integrated into the brand's DNA and the patient's daily life, driving measurable impact for our partners and better outcomes for patients worldwide."This partnership represents
More news about: Havas Health Network
Feb 26, 2026, 09:00 ET Volta Labs Ignites AGBT 2026 with Major Product Launches and Industry-Shaping Partnerships
1–compatible automation solutions. Volta will look to integrate the AXELIOS 1 SBX-D prep workflow into the Callisto platform. Callisto already has onboard DNA extraction workflows, enabling a streamlined, end-to-end solution.Our goal is to ensure customers adopting next-generation sequencers can rely
More news about: Volta Labs Inc.
Feb 26, 2026, 09:00 ET Volta Labs Ignites AGBT 2026 with Major Product Launches and Industry-Shaping Partnerships
1–compatible automation solutions. Volta will look to integrate the AXELIOS 1 SBX-D prep workflow into the Callisto platform. Callisto already has onboard DNA extraction workflows, enabling a streamlined, end-to-end solution.Our goal is to ensure customers adopting next-generation sequencers can rely
More news about: Volta Labs Inc.
Feb 26, 2026, 08:34 ET LC Sign Launches Official Mascot T.Tony, Humanizing Its Global LC-MaaS™ Strategy
proprietary LC-MaaS™ framework.Defining T.Tony: The Soul of CraftsmanshipT.Tony is more than a mascot; he embodies LC Sign's core DNA: reliability, precision, and a customer-first service culture. Inspired by the leadership of LC Sign CMO Tony Zhu and the symbolic strength of the tiger
More news about: LC SIGN Co., Ltd.
Feb 26, 2026, 08:00 ET Orsini Now Distributing Gene Therapies LYFGENIA™, ZYNTEGLO™, SKYSONA™
TestingPatients who have received LYFGENIA are likely to test positive by polymerase chain reaction (PCR) assays for HIV due to integrated BB305 LVV proviral DNA, resulting in a possible false-positive PCR assay test result for HIV. Therefore, patients who have received LYFGENIA should not be screened for HIV
More news about: Orsini
Feb 26, 2026, 06:00 ET The Cynosure Group Acquires Utah Development and Construction Creating a New Joint Partnership with Clyde Capital Group
of Clyde Capital Group, underscored the strong strategic alignment between the two firms. "What makes this partnership truly special is our shared DNA," he added. "We're aligned in strategy, values, and purpose — from our dedication to building community to a mutual commitment to philanthropy and high-impact
More news about: Clyde Capital Group
Feb 25, 2026, 22:28 ET UEC Research and Innovation newsletter highlights breakthroughs in neuroscience, robotics, augmented reality, quantum physics, and global collaboration
Research Highlights Hidden cellular signals shape memory: Researchers discovered that mitochondrial DNA released during cellular stress activates pathways that weaken neural connections, offering new insights into memory formation.
More news about: University of Electro-Communications
Feb 25, 2026, 11:42 ET Illinois State Senator Julie Morrison Earns National AMA Honor for Transformative Public Health Leadership
embodies the spirit of inquiry and excellence modeled by its namesake, Dr. Rosalind Franklin, whose Photo 51 was crucial to solving the structure of DNA. Recognized for its research in areas including neuroscience, brain-related diseases, inherited disorders, diabetes, obesity, and gait and balance, RFU
More news about: Rosalind Franklin University of Medicine and Science
Feb 25, 2026, 11:00 ET Dental Burs Market to Reach US$ 1,232.3 Million by 2033 on Growth of Dental Procedures and Technological Innovation
Microarrays Market by product (Consumables, Software and Services, Instruments), Type (DNA Microarrays, Protein Microarrays, Other Microarrays), Application (Research Application, Drug Discovery, Disease Diagnostics, Other Applications), End
More news about: Persistence Market Research Pvt. Ltd.